The [PEARL] Study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Everolimus (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms PEARL
- 01 Sep 2017 Planned number of patients changed from 132 to 46.
- 01 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Jan 2019.
- 01 Sep 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2018.